JORDAN GOOCH: Open Payments
NPI 1992364970 · LIVE OAK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,826 in 142 payments from 18 companies in 2025. Trend: 2023 $2,311 · 2024 $2,627 · 2025 $9,826
Consulting: $5,130Food & beverage: $3,165Travel & lodging: $991Speaker / faculty: $540
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 31 | $7,701 |
| ABBVIE INC. | 33 | $649 |
| Janssen Biotech, Inc. | 16 | $259 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $255 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $173 |
| Gilead Sciences, Inc. | 5 | $106 |
| Celltrion USA Inc. | 4 | $91 |
| Lilly USA, LLC | 4 | $84 |
| Ipsen Biopharmaceuticals, Inc | 4 | $74 |
| Phathom Pharmaceuticals, Inc. | 6 | $71 |
Products named: REZDIFFRA, TREMFYA, RINVOQ, XIFAXAN, ENTYVIO, EOHILIA, MAVYRET, SKYRIZI.
Industry payments across TX — which companies pay providers there.
